This results in increased production of RANKL, IL-6, vascular endothelial growth factor (VEGF), and tumor necrosis factor-a (TNF-α) by bone marrow stromal cells, further enhancing tumor cell growth, angiogenesis, and bone resorption (29). The gene discussed is IL6; the disease is neoplasm.